We are live on ! Find out more
DA

Denali Advisors Portfolio holdings

AUM $900M
1-Year Est. Return 28.25%
This Fund
S&P 500
This Quarter Est. Return
+7.18%
1 Year Est. Return
+28.25%
3 Year Est. Return
+85.79%
5 Year Est. Return
+102.58%
10 Year Est. Return
+285.17%
AUM
$285M
AUM Growth
+$44.5M
Cap. Flow
+$32.5M
Cap. Flow %
11.4%
Top 10 Hldgs %
16.67%
Holding
533
New
97
Increased
181
Reduced
101
Closed
64

Sector Composition

Rank Sector Weight
1 Financials 31.47%
2 Industrials 14.12%
3 Consumer Discretionary 12.34%
4 Technology 7.69%
5 Healthcare 6.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PMTS icon
201
CPI Card Group
PMTS
$224M
$244K 0.09%
10,500
+7,800
+289% +$250K
ASRT
202
DELISTED
Assertio
ASRT
$231K 0.08%
+2,847
New +$265K
EXPD icon
203
Expeditors International
EXPD
$22.9B
$230K 0.08%
1,900
-2,011
-51% -$229K
RGP icon
204
Resources Connection
RGP
$129M
$228K 0.08%
14,500
+7,400
+104% +$115K
FONR
205
DELISTED
Fonar
FONR
$226K 0.08%
13,200
+9,900
+300% +$165K
LOVE icon
206
LoveSac
LOVE
$239M
$224K 0.08%
+8,300
New +$212K
NMIH icon
207
NMI Holdings
NMIH
$3.25B
$222K 0.08%
8,600
PLX icon
208
Protalix BioTherapeutics
PLX
$191M
$220K 0.08%
+110,200
New +$263K
UONEK icon
209
Urban One Class D
UONEK
$22.9M
$210K 0.07%
3,500
+2,560
+272% +$145K
DXLG icon
210
Destination XL Group
DXLG
$34.7M
$208K 0.07%
+42,500
New +$200K
VTLE
211
DELISTED
Vital Energy
VTLE
$208K 0.07%
+4,600
New +$208K
KREF
212
KKR Real Estate Finance Trust
KREF
$472M
$206K 0.07%
16,900
ELVN icon
213
Enliven Therapeutics
ELVN
$3.78B
$202K 0.07%
+9,900
New +$200K
CPRX
214
DELISTED
Catalyst Pharmaceutical
CPRX
$200K 0.07%
+14,900
New +$214K
URGN icon
215
UroGen Pharma
URGN
$2B
$197K 0.07%
+19,000
New +$210K
TCS
216
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
$194K 0.07%
4,127
+3,627
+725% +$161K
EBF icon
217
Ennis
EBF
$546M
$194K 0.07%
+9,500
New +$192K
IESC icon
218
IES Holdings
IESC
$12.5B
$193K 0.07%
+3,400
New +$162K
IIIN icon
219
Insteel Industries
IIIN
$633M
$193K 0.07%
+6,200
New +$184K
PMVP icon
220
PMV Pharmaceuticals
PMVP
$66.1M
$191K 0.07%
+30,500
New +$160K
ABCB icon
221
Ameris Bancorp
ABCB
$5.89B
$186K 0.07%
5,437
+5,300
+3,869% +$176K
EVI icon
222
EVI Industries
EVI
$180M
$185K 0.06%
8,400
+7,800
+1,300% +$159K
VKTX icon
223
Viking Therapeutics
VKTX
$4.04B
$185K 0.06%
11,400
+8,100
+245% +$170K
RCKY icon
224
Rocky Brands
RCKY
$304M
$183K 0.06%
8,700
+7,700
+770% +$169K
MHH icon
225
Mastech Digital
MHH
$93.1M
$180K 0.06%
+18,200
New +$179K

Similar funds

Denali Advisors's Q2 2023 Portfolio in Review

As of Q2 2023, Denali Advisors held 533 positions worth $285M, up 18% from $240M the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Denali Advisors deployed $32.5M of net new capital in Q2 2023, opening 97 new positions and adding to 181 existing holdings. Its largest new stake was Berkshire Hathaway Class B: 3,500 shares worth $1.19M.

By sector, the portfolio is most concentrated in Financials at 31% of assets, down from 31% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was M.D.C. Holdings, Inc., an estimated $4.9M trimmed.

  • Denali Advisors's largest Q2 2023 buy was Berkshire Hathaway Class B: 3,500 shares worth $1.19M.
  • Denali Advisors added most to Textainer Group Holdings limited in Q2 2023, an estimated $2.69M increase.
  • Denali Advisors's biggest Q2 2023 reduction was M.D.C. Holdings, Inc., cutting an estimated $4.9M.
  • Denali Advisors fully exited Kennedy-Wilson Holdings in Q2 2023, selling an estimated $3.99M.
  • Denali Advisors's ten largest holdings make up 17% of its $285M portfolio in Q2 2023.
  • Denali Advisors opened 97 new positions and closed 64 in Q2 2023.
  • Denali Advisors's portfolio value rose 18% quarter-over-quarter to $285M.

Based on Denali Advisors's 13F filing for Q2 2023, filed 18 Jul 2023.